A Korean conglomerate may buy control of Zymos.
- Share via
The Sunnyvale, Calif.-based chip maker said it and Intermedics, which currently owns 47% of Zymos, have entered into a letter of intent with Daewoo Corp. of Seoul, South Korea, for Daewoo to obtain controlling interest in Zymos. A definitive agreement is expected by April 14.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
